{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T18:53:47Z","timestamp":1782154427484,"version":"3.54.5"},"reference-count":49,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003197","name":"Italian Medicines Agency","doi-asserted-by":"publisher","award":["101157011"],"award-info":[{"award-number":["101157011"]}],"id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009702","name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009702","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jtha.2026.02.026","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T17:16:55Z","timestamp":1774286215000},"page":"2355-2371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gene therapy for hemophilia: psychological perspectives on decision making and treatment outcomes"],"prefix":"10.1016","volume":"24","author":[{"given":"Aida","family":"Peyvandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Peyvandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Miesbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Cutica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.02.026_bib1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.7326\/M19-1208","article-title":"Establishing the prevalence and prevalence at birth of hemophilia in males: a meta-analytic approach using national registries","volume":"171","author":"Iorio","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2026.02.026_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ajem.2022.02.045","article-title":"High risk and low prevalence diseases: hemophilia emergencies","volume":"56","author":"Alblaihed","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jtha.2026.02.026_bib3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1365-2516.2012.02909.x","article-title":"Guidelines for the management of hemophilia","volume":"19","author":"Srivastava","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.02.026_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-021-00278-x","article-title":"Haemophilia","volume":"7","author":"Berntorp","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"suppl 6","key":"10.1016\/j.jtha.2026.02.026_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the Management of Hemophilia panelists and co-authors. WFH guidelines for the management of hemophilia, 3rd edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.jtha.2026.02.026_bib6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/a-1175-6530","article-title":"The evolution of hemophilia care: clinical and laboratory advances, opportunities, and challenges","volume":"40","author":"Trinchero","year":"2020","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.jtha.2026.02.026_bib7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev-med-043021-033013","article-title":"Adeno-associated virus gene therapy for hemophilia","volume":"74","author":"Samelson-Jones","year":"2023","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jtha.2026.02.026_bib8","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3390\/v15030698","article-title":"Viral vectors in gene therapy: where do we stand in 2023?","volume":"15","author":"Lundstrom","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.jtha.2026.02.026_bib9","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1134\/S0006297923120179","article-title":"Viral vectors in gene replacement therapy","volume":"88","author":"Minskaia","year":"2023","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.jtha.2026.02.026_bib10","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1056\/NEJMoa2104205","article-title":"Multiyear factor VIII expression after AAV gene transfer for hemophilia A","volume":"385","author":"George","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.02.026_bib11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.30574\/gscarr.2023.15.3.0192","article-title":"Gene therapy for hemophilia: current status and future perspectives","volume":"15","author":"Anguiano S\u00e1nchez","year":"2023","journal-title":"GSC Adv Res Rev"},{"key":"10.1016\/j.jtha.2026.02.026_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/20406207231165857","article-title":"Considerations for shared decision management in previously untreated patients with hemophilia A or B","volume":"14","author":"Astermark","year":"2023","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.jtha.2026.02.026_bib13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/hae.14304","article-title":"Patients\u2019 and parents\u2019 satisfaction with, and preference for, haemophilia A treatments: a cross-sectional, multicentre, observational study","volume":"27","author":"Park","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.02.026_bib14","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jtha.2023.12.018","article-title":"Knowledge and attitudes toward gene therapy of a cohort of Italian patients with hemophilia","volume":"22","author":"Cutica","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.02.026_bib15","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1111\/hae.14440","article-title":"Implications of haemophilia gene therapy for the changing role of the multidisciplinary team","volume":"28","author":"Miesbach","year":"2022","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.jtha.2026.02.026_bib16","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/hae.14378","article-title":"An exploration of why men with severe haemophilia might not want gene therapy: the Exigency study","volume":"27","author":"Fletcher","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.02.026_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2478\/jhp-2024-0007","article-title":"A multi-stakeholder collaborative approach to awareness, education and support needed in the haemophilia gene therapy patient journey \u2013 a report on insights from a European patient advisory board","volume":"11","author":"O\u2019Mahony","year":"2024","journal-title":"J Haem Pract"},{"key":"10.1016\/j.jtha.2026.02.026_bib31","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/hae.15104","article-title":"Voices of patients with hemophilia: life-changing gene therapy","volume":"30","author":"Pietu","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.02.026_bib37","article-title":"Gene therapy in hemophilia: a transformational patient experience","volume":"10","author":"Rasul","year":"2023","journal-title":"J Patient Exp"},{"issue":"suppl 1","key":"10.1016\/j.jtha.2026.02.026_bib38","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1182\/blood-2023-179431","article-title":"Health-related quality of life in adults with hemophilia B after receiving gene therapy with fidanacogene elaparvovec","volume":"142","author":"von Mackensen","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.02.026_bib36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13023-022-02256-2","article-title":"The experiences of people with haemophilia and their families of gene therapy in a clinical trial setting: regaining control, the Exigency study","volume":"17","author":"Fletcher","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jtha.2026.02.026_bib25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.17225\/jhp00174","article-title":"The patient gene therapy journey: findings from qualitative interviews with trial participants at one UK haemophilia centre","volume":"8","author":"Aradom","year":"2021","journal-title":"J Haem Pract"},{"key":"10.1016\/j.jtha.2026.02.026_bib39","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2147\/PPA.S239810","article-title":"The patient experience of gene therapy for hemophilia: qualitative interviews with trial patients","volume":"14","author":"Miesbach","year":"2020","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jtha.2026.02.026_bib46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/hae.70165","article-title":"A comprehensive approach: addressing psychological needs in gene therapy for haemophilia","volume":"32","author":"Peyvandi","year":"2026","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.02.026_bib41","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s13023-024-03181-2","article-title":"A 360-degree perspective on adeno-associated virus (AAV)-based gene therapy for haemophilia: insights from the physician, the nurse and the patient","volume":"19","author":"Miesbach","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jtha.2026.02.026_bib18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/hae.14908","article-title":"Perspectives and perception of haemophilia gene therapy by French patients","volume":"30","author":"Pietu","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.02.026_bib24","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s13023-023-02977-y","article-title":"Educational needs of patients, families, and healthcare professionals to support the patient journey in haemophilia gene therapy in the UK","volume":"18","author":"Boyce","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jtha.2026.02.026_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12783","article-title":"Challenges and knowledge gaps facing hemophilia carriers today: perspectives from patients and health care providers","volume":"6","author":"Chaigneau","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.02.026_bib47","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2147\/PPA.S355627","article-title":"The hemophilia gene therapy patient journey: questions and answers for shared decision-making","volume":"16","author":"Wang","year":"2022","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jtha.2026.02.026_bib30","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/hae.14572","article-title":"Examining patient and professional perspectives in the UK for gene therapy in haemophilia","volume":"28","author":"Woollacott","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.02.026_bib23","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/hae.14188","article-title":"Parental perspectives on gene therapy for children with haemophilia: the Exigency study","volume":"27","author":"Khair","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.02.026_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/hae.14190","article-title":"Patient perspectives regarding gene therapy in haemophilia: interviews from the PAVING study","volume":"27","author":"van Overbeeke","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.02.026_bib48","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/rth2.12326","article-title":"Hemophilia gene therapy knowledge and perceptions: results of an international survey","volume":"4","author":"Peyvandi","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.02.026_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40271-019-00395-6","article-title":"Patient perspectives on novel treatments in haemophilia: a qualitative study","volume":"13","author":"van Balen","year":"2020","journal-title":"Patient"},{"key":"10.1016\/j.jtha.2026.02.026_bib17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/hae.13673","article-title":"Members of the WFH Gene Therapy Round Table Program Committee and Organizing Committee. The 1st WFH Gene Therapy Round Table: understanding the landscape and challenges of gene therapy for haemophilia around the world","volume":"25","author":"Pierce","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.02.026_bib42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1055\/s-2004-825637","article-title":"Hemophilia gene transfer: comparison with conventional protein replacement therapy","volume":"30","author":"Ragni","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.02.026_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-0044-1787664","article-title":"Patient perspective on disease burden and gene therapy for hemophilia A and B: the \u201cHaemvolution for Patients\u201d Italian survey","volume":"51","author":"Mansueto","year":"2025","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.02.026_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/hae.15125","article-title":"UKHCDO gene therapy taskforce: guidance for implementation of haemophilia gene therapy into routine clinical practice for adults","volume":"31","author":"Chowdary","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.02.026_bib49","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/hae.15100","article-title":"Development of the World Federation of Hemophilia Shared Decision-Making Tool","volume":"30","author":"Coffin","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.02.026_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1017\/S1930297500000334","article-title":"A Domain-Specific Risk-Taking (DOSPERT) scale for adult populations","volume":"1","author":"Blais","year":"2006","journal-title":"Judgm Decis Mak"},{"key":"10.1016\/j.jtha.2026.02.026_bib28","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1177\/0013164495055005017","article-title":"Decision-making style: the development and assessment of a new measure","volume":"55","author":"Scott","year":"1995","journal-title":"Educ Psychol Meas"},{"key":"10.1016\/j.jtha.2026.02.026_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/jhp-2025-0001","article-title":"\u201cI\u2019d go on a hike with my kids\u2026 that would make me feel so happy.\u201d Recognising what people with haemophilia B identify as meaningful when considering personal goals and the potential for gene therapy","volume":"12","author":"Khair","year":"2025","journal-title":"J Haem Pract"},{"key":"10.1016\/j.jtha.2026.02.026_bib33","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1038\/s41467-020-20096-1","article-title":"Patient and public perspectives on cell and gene therapies: a systematic review","volume":"11","author":"Aiyegbusi","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2026.02.026_bib34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1037\/a0038088","article-title":"A meta-analysis on age differences in risky decision making: adolescents versus children and adults","volume":"141","author":"Defoe","year":"2015","journal-title":"Psychol Bull"},{"key":"10.1016\/j.jtha.2026.02.026_bib35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1749-6632.2011.06200.x","article-title":"Age differences in risky choice: a meta-analysis","volume":"1235","author":"Mata","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jtha.2026.02.026_bib40","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/hae.70005","article-title":"Recommendations for psychosocial support during gene therapy: results from an EAHAD interdisciplinary roundtable","volume":"31","author":"Teela","year":"2025","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.02.026_bib43","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/hae.14774","article-title":"Expectation and loss when gene therapy for haemophilia is not an option: an Exigency sub-study","volume":"29","author":"Fletcher","year":"2023","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.02.026_bib44","first-page":"161","article-title":"Medical decision making and risky choices: psychological and medicolegal consequences of HIV and HCV contamination of blood products","author":"Riva","year":"2017","journal-title":"HIV AIDS (Auckl)"},{"key":"10.1016\/j.jtha.2026.02.026_bib45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/hae.70113","article-title":"The WFH guidelines for the management of haemophilia: AAV gene therapy, 2025","volume":"32","author":"Pierce","year":"2026","journal-title":"Haemophilia"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626001467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626001467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T18:44:06Z","timestamp":1782153846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626001467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1538783626001467"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.02.026","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene therapy for hemophilia: psychological perspectives on decision making and treatment outcomes","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}